Nadim Mahmud, MD, MS, MPH, MSCE

Gastroenterology
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
View 1 additional location
Make an appointmentCall 215-349-8222
Headshot of Nadim Mahmud, MD, MS, MPH, MSCE
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
  • Assistant Professor of Medicine in Biostatistics and Epidemiology

My education and training

  • Medical School: Stanford University School of Medicine
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Mahmud is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Ochoa-Allemant P, Kiran A, Mezzacappa C, Kaplan DE, Mahmud N. Steatotic Liver Disease has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the US Veterans Health System. , Am J Gastroenterol, 121(7): 2026

Hatipoglu D, Mahmud N Integrated care is necessary, but not sufficient, for equity in hepatocellular carcinoma outcomes , Liver Transpl, 32(7): 2026

Hatipoglu D, Kiran A, Mahmud N Guidelines in Practice: Preoperative Risk Assessment and Management in Patients With Cirrhosis , Am J Gastroenterol: 2026

Agins J, Blandon C, Kaplan DE, John B, Mahmud N, Goldberg DS Predicting severe liver dysfunction following locoregional therapy for early- and intermediate-stage hepatocellular carcinoma , Liver Transpl: 2026

McCullough AA, Mahmud N, Reddy KR, Bittermann T Delisting for clinical improvement as a proxy for recompensated cirrhosis on the U.S. liver transplant waitlist: A retrospective cohort study , Liver Transpl: 2026

Mahmud N, Schechter MS, Zhang S, Mezzacappa C, Ochoa-Allemant P, Kaplan DE, Serper M Intravenous albumin after outpatient paracentesis reduces the risk of AKI hospitalization: A national cohort study , Hepatology: 2026

Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, DE Feria A, Marzolf A, Owens AT Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy , J Card Fail Intersect, 2(2): 2026

Goebel AM, Sheng E, Ochoa-Allemant P, Reza N, Mahmud N. A Meta-Epidemiological Analysis of Sex Disparities in Hepatology Clinical Trials , Clin Gastroenterol Hepatol, 24(2): 2026,563-565

Reza N, Mahmud N, Austin MA, Boakye E, Duqueney E, Patel P, de Feria A, Hornsby N, Marzolf A, Owens AT Association between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten , J Card Fail: 2026,Online ahead of print

Khan N, Sundararajan R, Patel D, Patel M, Bahirwani J, Mahmud N Comparative Risk of Serious Infections Associated With Treatment of Inflammatory Bowel Disease , Inflamm Bowel Dis, 32(2): 2026,199-206

View all publications